Chia Tai Tianqing Pharmaceutical (guangzhou) Co., Ltd.

This is an early-stage study to check the safety of a new inhaled spray called TQC3302, which is being developed for Chronic Obstructive Pulmonary Disease (COPD). The study involves 57 healthy adult volunteers who will use the spray so researchers can see how their bodies react t…